We are live on ! Find out more
JLBC

J.L. Bainbridge & Co Portfolio holdings

AUM $1.27B
1-Year Est. Return 26.55%
This Fund
S&P 500
This Quarter Est. Return
-16.79%
1 Year Est. Return
+26.55%
3 Year Est. Return
+93.81%
5 Year Est. Return
+120.16%
10 Year Est. Return
AUM
$673M
AUM Growth
-$205M
Cap. Flow
-$52.3M
Cap. Flow %
-7.78%
Top 10 Hldgs %
70.02%
Holding
91
New
2
Increased
28
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$10.5M
2
AMZN icon
Amazon
AMZN
+$4.93M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.91M
4
AXP icon
American Express
AXP
+$3.8M
5
CMCSA icon
Comcast
CMCSA
+$1.75M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$45.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$20.9M
3
T icon
AT&T
T
+$7.93M
4
AAPL icon
Apple
AAPL
+$1.46M
5
META icon
Meta Platforms (Facebook)
META
+$886K

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Communication Services 26.67%
3 Healthcare 11.68%
4 Financials 6.32%
5 Consumer Discretionary 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SO icon
51
Southern Company
SO
$102B
$374K 0.06%
5,245
-50
-0.9% -$3.67K
SCHW
52
Charles Schwab
SCHW
$191B
$366K 0.05%
5,796
+195
+3% +$13.4K
JPM icon
53
JPMorgan Chase
JPM
$951B
$347K 0.05%
3,080
+50
+2% +$6.2K
SVC
54
Service Properties Trust
SVC
$1.02B
$345K 0.05%
13,175
-1,145
-8% -$39.5K
COP icon
55
ConocoPhillips
COP
$157B
$321K 0.05%
3,573
-450
-11% -$46.4K
SPGI icon
56
S&P Global
SPGI
$131B
$306K 0.05%
908
CVS icon
57
CVS Health
CVS
$119B
$268K 0.04%
2,891
-468,616
-99% -$45.7M
BAC icon
58
Bank of America
BAC
$436B
$259K 0.04%
8,324
IBDP
59
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$257K 0.04%
10,366
-762
-7% -$18.9K
IGIB icon
60
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.7B
$250K 0.04%
4,888
PFE icon
61
Pfizer
PFE
$159B
$250K 0.04%
4,767
+251
+6% +$12.8K
TFC icon
62
Truist Financial
TFC
$61.6B
$244K 0.04%
5,141
RY icon
63
Royal Bank of Canada
RY
$283B
$242K 0.04%
2,500
ABBV icon
64
AbbVie
ABBV
$451B
$238K 0.04%
1,557
FNDA icon
65
Schwab Fundamental US Small Company Index ETF
FNDA
$9.15B
$238K 0.04%
10,532
NSC icon
66
Norfolk Southern
NSC
$78.3B
$227K 0.03%
1,000
COST icon
67
Costco
COST
$419B
$223K 0.03%
466
OTIS icon
68
Otis Worldwide
OTIS
$27.3B
$217K 0.03%
3,066
+12
+0.4% +$884
IJR icon
69
iShares Core S&P Small-Cap ETF
IJR
$110B
$216K 0.03%
2,337
-112
-5% -$11.1K
PEP icon
70
PepsiCo
PEP
$193B
$211K 0.03%
1,269
-123
-9% -$20.7K
XYL icon
71
Xylem
XYL
$26B
$211K 0.03%
2,700
TD icon
72
Toronto Dominion Bank
TD
$199B
$210K 0.03%
3,204
LMT icon
73
Lockheed Martin
LMT
$130B
$202K 0.03%
470
ESBA icon
74
Empire State Realty Series ES
ESBA
$1.3B
$172K 0.03%
24,206
RYAM icon
75
Rayonier Advanced Materials
RYAM
$582M
$104K 0.02%
39,565

Similar funds

J.L. Bainbridge & Co's Q2 2022 Portfolio in Review

As of Q2 2022, J.L. Bainbridge & Co held 91 positions worth $673M, down 23% from $878M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

J.L. Bainbridge & Co withdrew a net $52.3M in Q2 2022, closing 15 positions and reducing 27 holdings. Its most notable exit was Broadcom, an estimated $256K position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, J.L. Bainbridge & Co opened a new position in Eaton worth $1M.

  • J.L. Bainbridge & Co's largest Q2 2022 buy was Eaton: 7,942 shares worth $1M.
  • J.L. Bainbridge & Co added most to Warner Bros in Q2 2022, an estimated $10.5M increase.
  • J.L. Bainbridge & Co's biggest Q2 2022 reduction was CVS Health, cutting an estimated $45.7M.
  • J.L. Bainbridge & Co fully exited Broadcom in Q2 2022, selling an estimated $256K.
  • J.L. Bainbridge & Co's ten largest holdings make up 70% of its $673M portfolio in Q2 2022.
  • J.L. Bainbridge & Co opened 2 new positions and closed 15 in Q2 2022.
  • J.L. Bainbridge & Co's portfolio value fell 23% quarter-over-quarter to $673M.

Based on J.L. Bainbridge & Co's 13F filing for Q2 2022, filed 4 Aug 2022.